Skip to content
Back to announcement

20240520_KLBF_Keterbukaan Informasi terkait Aksi Korporasi_31641211_lamp2.pdf

Other Text extracted KLBF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 7

Page 1
                                PT KALBE FARMA TBK
                                   ("the Company")


                         ANNOUNCEMENT OF
      SUMMARY OF ANNUAL GENERAL MEETING OF SHAREHOLDERS AND
        EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS AND
     THE SCHEDULE AND PROCEDURES OF CASH DIVIDEND DISTRIBUTION

The Board of Directors of the Company hereby announces the Annual General Meeting of
Shareholders (“AGMS”) and the Extraordinary General Meeting of Shareholders (“EGMS”).
In compliance with the OJK Regulation No. 15/POJK.04/2020 on the Planning and Holding
of the General Meetings of Shareholders of Public Companies, hereby we deliver the
summary of AGMS and EGMS as follows:

1.     AGMS :

       A.    Place, date, and time of the AGMS:

             Day / date    :       Thursday, May 16, 2024
             Location      :       Ruang Auditorium Lt. 4
                                   Kalbe Business Innovation Center
                                   Jalan Pulogadung No. 23, Kav. No. II G.5, KIP
                                   Kel. Jatinegara, Kec. Cakung, Jakarta Timur
             Time          :       10.21 - 11.25 Western Indonesian Time

       B.    The AGMS Agenda:
             1. Approval of the Annual Report of the Company for the year ended
                December 31, 2023, including the Activity Report of the Company, the
                Report of the Supervisory Role of the Board of Commissioners, approval
                and ratification of the Company’s Audited Financial Statements for the year
                ended December 31, 2023, and to grant a release and discharge from their
                responsibilities to all members of the Board of Commissioners and Board
                of Directors for their management and supervision actions during the
                financial year ended December 31, 2023 (acquit et de charge);
             2. Approval on the appropriation of the Company’s Net Profits for the financial
                year ended December 31, 2023;
             3. Changes in the Composition of the Company’s Management;
             4. Determination of salary and/or honorarium of the members of the Board of
                Commissioners and the Board of Directors and to authorize the Board of
                Commissioners to determine the salary and/or honorarium of the members
                of the Board of Directors;
             5. Appointment of a Registered Public Accountant Firm (including a
                Registered Public Accountant who is a member of a Registered Public
                Accountant Firm) to audit/examine the Company’s books for the financial
                year ended December 31, 2024.
Page 2
      C.     AGMS was led by Bernadette Ruth Irawati Setiady as President
             Commissioner and attended by members of the Board of Commissioner and
             Board of Directors as follows:

             Commissioner                       : BUDI DHARMA WREKSOATMODJO
             Independent Commissioner           : LILIS HALIM
             Independent Commissioner           : RHENALD KASALI
             President Director                 : VIDJONGTIUS
             Director                           : BERNADUS KARMIN WINATA
             Director                           : SIE DJOHAN
             Director                           : MULIALIE
             Director                           : JOS IWAN ATMADJAJA
             Director                           : KARTIKA SETIABUDY

      D.    The number of shares in the Company with valid voting rights presented at
            the AGMS was 41,607,672,880 shares or equal to 89.95% of 46,255,641,410
            of the total shares in the Company with valid voting rights.

      E.     The Shareholders and the authorized Shareholders were given the
             opportunity to raise questions and/or opinions to each of the AGMS agendas,
             but there were no Shareholders and their proxies asked questions and/or
             opinions.

      F.     The mechanism of resolution-making in the AGMS is as follows:
             The decision-making of all the agendas is carried out based on mutual
             consensus, in terms of deliberation consensus is not sufficient, decision-
             making would be done by voting.

      G.     The results of the AGMS are as follows:

First Agenda

     Against          Abstain        In Favor Votes     Total in Favor Votes        (%)
      Votes            Votes
   53,826,583       435,406,149      41,118,440,148         41,553,846,297         99.87

* Total in Favor Votes is in Favor Votes added with Abstain Votes (In accordance
with the provisions of Article 23 paragraph (7) of the Articles of Association,
Abstain Votes is considered equal to a majority vote of shareholders that give
votes)

Approve and ratify the Annual Report of the Company for the year ended
December 31, 2023, including the Activity Report of the Company, the Report of
the Supervisory Role of the         Board of Commissioners, the Company’s
Consolidated Financial Statements for the year ended December 31, 2023, and
to grant a release and discharge from their responsibilities to all members of the
Board of Commissioners and Board of Directors for their management a nd
supervision actions during the financial year ended December 31, 2023 (acquit et
de charge).
Page 3
Second Agenda

 Against Votes         Abstain Votes        In Favor Votes Total in Favor      (%)
                                                               Votes
          0            313,446,412       41,294,226,468    41,607,672,880     100.00
* Total in Favor Votes is In Favor Votes added with Abstain Votes (In accordance
with the provisions of Article 23 paragraph (7) of the Articles of Association,
Abstain Votes is considered equal to a majority vote of shareholders that give
votes)

a. Approved the use of the Company’s net profits in the current year attributable to the
    Owners of the Parent Entity for the fiscal year 2023, amounting to, as follows:
     i. Rp31 (thirty-one Rupiah) per share as cash dividends which will be distributed to
        shareholders listed in the shareholder register in accordance with the applicable
        scheduling provisions, taking into account the applicable tax regulations;
    ii. In the amount of Rp27,667,480,400 (twenty-seven billion six hundred sixty-seven
        million four hundred eighty thousand four hundred Rupiah), set aside as a Reserve
        Fund;
   iii. The remainder is recorded as the Company's retained earnings.
b. Delegated authority to the Board of Directors of the Company to perform all
    and any necessary actions in connection with the distribution of cash
    dividend, including but not limited to determining the time, date and method of
    payment                 of                 the              cash                dividend.

Third Agenda

     Against         Abstain        In Favor Votes      Total in Favor        (%)
      Votes           Votes                                  Votes
  8.142.173.614     360.388.431      33.105.110.835      33.465.499.266      80,43
* Total in Favor Votes is in Favor Votes added with Abstain Votes (In accordance
with the provisions of Article 23 paragraph (7) of the Articles of Association,
Abstain Votes is considered equal to a majority vote of shareholders that give
votes)

a. Accepting the resignation of Vidjongtius from his position as President
   Director, Bernadus Karmin Winata from his position as Director, Bernadet te
   Ruth Irawati Setiady from her position as President Commissioner, and Budi
   Dharma Wreksoatmodjo from his position as Commissioner, with gratitude for
   their services and performance in the Company.
b. Granting a release and discharge of liability (acquit et de charge) to members
   of the Board of Commissioners and Board Directors of the Company who shall
   have end of tenure soon after the Meeting closed for their respective
   management and supervisory actions during their tenure, as long as that
   action is reflected in Company’s books or notes.
c. Appointing members of the Board of Directors and Board of Commissioners of
   the Company for the term of office until the closing of the Company's Annual
   General Meeting of Shareholders to be held in 2026, with the compositio n as
   follows:
   Directors:
   President Director           :      BERNADETTE RUTH IRAWATI SETIADY;
   Director                     :      SIE DJOHAN;
   Director                     :      MULIALIE;
   Director                     :      JOS IWAN ATMADJAJA;
   Director                     :      KARTIKA SETIABUDY;
Page 4
   Board of Commissioners:
   President Commissioner       :      VIDJONGTIUS
   Commissioner                 :      SANTOSO OEN
   Commissioner                 :      RONNY HADIANA
   Commissioner                 :      FERDINAND ARYANTO
   Independent Commissioner     :      LILIS HALIM
   Independent Commissioner     :      RHENALD KASALI


d. Granted authority with substitution rights to the Board of Dire ctors of the
   Company to perform all actions, in relation to the changes in the composition
   of the Board of Directors and Board of Commissioners including but not
   limited to make or request to be made and to sign all deeds made before the
   Notary, and notify the authorities and do all and any necessary action related
   to    the   decisions    in     accordance     with   prevailing  regulations .


Fourth Agenda

 Against Votes     Abstain Votes         In Favor       Total in Favor        (%)
                                          Votes              Votes
   2,364,928,801     380,027,331      38,862,716,748     39,242,744,079     94.32%
* Total in Favor Votes is In Favor Votes added with Abstain Votes (In accordance
with the provisions of Article 23 paragraph (7) of the Articles of Association,
Abstain Votes is considered equal to a majority vote of shareholders that giv e
votes)

a. To determine and to approve the salary and/or honorarium of members of the
   Board of Commissioners for the year 2024, a maximum amount not exceeding
   0.1% (zero point one percent) of the Company’s net sales of the year 2023,
   and authorizing the Board of Commissioners to determine its allocation, by
   considering   the   input/recommendations    from   the  Nomination    and
   Remuneration Committee,
b. To authorize the Board of Commissioners to determine the salary and/or
   honorarium of the members of the Board of Dir ectors, by considering the
   recommendation from the Nomination and Remuneration Committee.

Fifth Agenda

     Against       Abstain Votes         In Favor       Total in Favor        (%)
      Votes                               Votes              Votes
  1,601,871,250      316,007,612      39,689,794,018     40,005,801,630      96.15
* Total in Favor Votes is In Favor Votes added with Abstain Votes (In accordance
with the provisions of Article 23 paragraph (7) of the Articles of Association,
Abstain Votes is considered equal to a majority vote of shareholders that give
votes)

a. Appointing the Public Accounting Firm Purwantono, Sungkoro & Surja to
   audit/examine the Company's books and records for the financial year ending
   on December 31, 2024.
b. Granting authority and power to the Board of Commissioners to appoint a
   replacement Public Accountant or dism iss the appointed Public Accountant, if
   for any reason based on the provision of the Capital Market in Indonesia, the
   appointed Public Accountant is unable to carry out or complete his duties .
Page 5
c. Granting authority and power to the Board of Directors with the approval of
   the Board of Commissioners to determine the honorarium of the Public
   Accountant and the terms of its appointment.

2. EGMS :
    A. Place, date, and time of the EGMS:
       Day / date        :     Thursday, May 16, 2024
       Location           :    Ruang Auditorium Lt. 4 Kalbe Business Innovation
                               Center Jalan Pulogadung No. 23, Kav. No. II G.5,
                               KIP Kel. Jatinegara, Kec. Cakung, Jakarta Timur
       Time              :     11.38 - 11.49 Western Indonesian Time

     B. The EGMS Agenda:
        Approval of the plan to buyback shares issued by the Company in accordance
        with OJK Regulation Number 29 of 2023 concerning the Buyback of Shares
        Issued by Public Companies.

     C. EGMS was led by Vidjongtius as President Commissioner and attended
        by members of the Board of Commissioner and Board of Directors as
        follows:

        Independent Commissioner      : LILIS HALIM
        Independent Commissioner      : RHENALD KASALI
        President Director            : BERNADETTE RUTH IRAWATI SETIADY
        Director                      : SIE DJOHAN
        Director                      : MULIALIE
        Director                      : JOS IWAN ATMADJAJA
        Director                      : KARTIKA SETIABUDY

     D. EGMS was attended by shareholders and shareholder proxies
        representing 41,456,690,068 shares, or 89.63% of the 46,255,641,410
        shares which constitute all valid voting shares issued by the Company
        (after deducting the number of shares that ha ve been repurchased by
        the Company).

     E. The Shareholders and the authorized Shareholders were given the
        opportunity to raise questions and/or opinions to each of the EGMS
        agenda, but there were no Shareholders and their proxies ask questions
        and/or opinions.

     F. The mechanism of resolution making in the EGMS are as follows:
        The decision-making of all the agenda are carried based on mutual
        consensus, in terms of deliberation for consensus is not sufficient,
        decision-making     would        be      done       by      voting.

     G. The results of the EGMS are as follows:

     Against         Abstain       In Favor Votes    Total in Favor Votes     (%)
      Votes           Votes
   84,110,207      158,535,619    41,214,044,242        41,372,579,861       99.80

* Total in Favor Votes is in Favor Votes added with Abstain Votes (In accordance
with the provisions of Article 23 paragraph (7) of the Articles of Association,
Abstain Votes is considered equal to a majority vote of shareholders that give
Page 6
votes)

a. Approve the buyback of shares issued by the Company with an estimated
maximum cost of Rp1,000,000,000,000,- (one trillion Rupiah), in compliance with
the laws and regulations applicable in the Capital Market, as announced in the
Disclosure of Information regarding the Share Buyback Plan of PT Kalbe Farma
Tbk, through the website of the Indonesia Stock Exchange ("IDX"), PT Kustodian
Sentral Efek Indonesia (application "eASY.KSEI"), and the Company's website on
April 05, 2024.
b. Approving and granting authority and power to the Board of Directors of the
    Company to take all necessary actions related to this decision in accordance
    with the laws and regulations applicable in the Capital Market, including but
    not limited to:
i. determining the buyback price of the shares issued by the Company;
ii. executing the transfer of the buyback shares in accordance with the applicable
OJK regulations.

The Board of Directors of the Company hereby also announces the schedule
and procedures of cash dividend distribution as follows:

Schedule of Cash Dividend Payment:

                            Activity                                      Date
     Cum Dividend in Regular and Negotiation Market                   28 May 2024
     Ex Dividend in Regular and Negotiation Market                    29 May 2024
     Cum Dividend in Cash Market                                      30 May 2024
     Ex Dividend in Cash Market                                       31 May 2024
     Recording Date of Shareholders Entitled to Dividend              30 May 2024
     Dividend Payment                                                 14 June 2024

Procedures of Cash Dividend Payment:

1.        This announcement constitutes an official notification from the Company,
          and the Company does not issue separate notifications to the
          Shareholders.

2.        Payment of cash dividends will be made to the Shareholders whose names
          are listed in the Share Register of the Company as of May 30, 2024, until
          the closing of trading of shares on the Indonesia Stock Exchange on that date,
          which is to be referred to as Recording Date of Shareholders Entitled to
          Dividend.

3.        For those Shareholders whose shares are placed in the collective custo dy
          of PT Kustodian Sentral Efek Indonesia (”KSEI”), the payment of dividends
          in accordance with the above schedule will be conducted through transfer
          through KSEI, and KSEI will subsequently distribute to the accounts of
          Securities Companies or Custodian Banks where the Shareholders keep
          their accounts.

4.        For those Shareholders holding script shares, whereby the shares are not
          placed under collective custody of KSEI, and wish to obtain dividend
          payment through transfer to their bank accounts, they may do so by
          informing the names and addresses of their banks as well as their account
          numbers at the latest on May 30, 2024, in writing to:
Page 7
                                Share Registrar (”BAE”)
                               PT Adimitra Jasa Korpora
                             Rukan Kirana Boutique Office
                      Jl, Kirana Avenue III Blok F3 No, 5, Jakarta
                     Telp : +6221 29745222 Fax : +6221 29289961

5.   The cash dividend will be taxed in accordance with the current taxation laws and
     regulations, The amount of tax imposed will be borne by the Shareholders concerned
     and deducted from the amount of cash dividends that the Shareholders' right
     concerned.

6.   Based on the prevailing tax laws and regulations, the cash dividend will be exempted
     from the tax object if it is received by domestic taxpayer shareholders in the form of
     legal entities and the Company does not deduct Income Tax on cash dividend paid,
     Cash dividends received by individual resident taxpayer shareholders will be
     exempted from tax objects as long as the dividend is invested in the territory of the
     Republic of Indonesia, For domestic taxpayers who do not meet the investment
     requirements as mentioned above, the dividend received by the person concerned
     will be subject to income tax ("PPh") in accordance with the provisions of the
     applicable laws, and the income tax must be paid by the domestic taxpayers
     concerned accordingly with the provisions of Government Regulation No, 9 of 2021
     concerning Tax Treatment to Support Ease of Doing Business.

7.   Shareholders may have dividend payment confirmation through a securities company
     and/or custodian bank where the shareholders open a securities account, then the
     shareholders must be responsible for reporting the dividend receipt referred to in the
     tax reporting for the tax year concerned in accordance with the applicable tax laws
     and regulations.

8.   For those Shareholders considered as Foreign Taxpayers whose tax deduction will
     use the rates based on the Double Tax Avoidance Agreement (P3B) must meet the
     requirements of the Director General of Taxes Regulation No, PER-25/PJ/2018
     concerning Procedures for Implementing Double Tax Avoidance Agreements, and
     submitting DGT forms that have been legalized by the Company Entering Exchanges
     Tax Office to KSEI or Registrar in accordance with KSEI rules and regulations,
     without said documents, the cash dividend paid will be charged Article 26 of Income
     Tax by 20%.

9.   For those Shareholders considered as Foreign Taxpayers whose shares were
     collected in the securities account in KSEI, the proof of dividend tax withholding will
     be available at the Securities Company and/or Custodian Bank where the
     Shareholders open their securities accounts and for the script Shareholders it will be
     available at the Registrar,



                                   Jakarta, May 20, 2024
                                    Board of Directors
                                   PT Kalbe Farma Tbk

File

File Open PDF
Source IDX
Size0.24 MB
Published20 May 2024
Pages7
Characters20,487
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 16 people and organisations named in the text · linked when the evidence is strong

linked org KALBE FARMA TBK p.1 ×8
linked person Bernadette Ruth Irawati Setiady p.2 ×3
linked person BUDI DHARMA WREKSOATMODJO p.2 ×2
linked person LILIS HALIM p.2 ×3
linked person RHENALD KASALI p.2 ×3
linked person BERNADUS KARMIN WINATA p.2 ×2
linked person SIE DJOHAN p.2 ×3
linked person JOS IWAN ATMADJAJA p.2 ×3
linked person KARTIKA SETIABUDY p.2 ×3
linked person SANTOSO OEN p.4
linked person RONNY HADIANA p.4
linked person FERDINAND ARYANTO p.4
possible — Vidjongtius · President Commissioner p.5
unresolved org Indonesia Stock Exchange p.6 ×2
unresolved org PT Kustodian Sentral Efek Indonesia p.6 ×3
unresolved org PT Adimitra Jasa Korpora Rukan Kirana Boutique Office p.7

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result